Chicago Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Chicago Capital Management’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-39,437	Closed	-$1.61M	–	45
2024 Q2	$1.61M	Hold	39,437	–	–	1.25%	30
2024 Q1	$1.67M	Buy	39,437 +25,937	+192%	+$1.09M	1.75%	22
2023 Q4	$572K	Buy	+13,500	New	+$388K	0.91%	25

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Chicago Capital Management's CERE Position: Q3 2024 in Review

Chicago Capital Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 39,437 shares — an estimated $1.61M sold.

Chicago Capital Management first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $1.67M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Chicago Capital Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Chicago Capital Management sold 39,437 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.61M.
Chicago Capital Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
Chicago Capital Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.67M in Q1 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Chicago Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.